Sort
21,453 grants matching “tuberculosis”
Metabolic determinants of barrier function in rifampin-sensitive and -resistant Mtb
$463,181Kyu Y Rhee · Brigham And Women'S Hospital · U19 · FY2022 · AI
Control of Bacterial Toxins by Viruses and Plasmids
$463,104Randall K Holmes · University Of Colorado Denver · R37 · FY2008 · AI
Innovative PK/PD Approaches to Optimize TBM Treatment in Children (PATCH Study)
$462,969Kelly E. Dooley · Johns Hopkins University · R01 · FY2015 · HD
BD FACSymphony
$462,958Joanne Turner · Texas Biomedical Research Institute · S10 · FY2020 · OD
Biocomputation across distributed private datasets to enhance drug discovery
$462,944Sean Ekins · Collaborative Drug Discovery, Inc. · R44 · FY2013 · TR
A Novel CDN Sensor-Adaptor System for Host Defense Against Infection
$462,927John D Macmicking · Yale University · R01 · FY2019 · AI
Hollow Fiber Infection Model to Delineate Combination Drug Interaction for Different MTB Metabolic Populations and using Different Pharmacokinetic Profiles
$462,859George Louis Drusano · University Of Florida · P01 · FY2020 · AI
DYNAMICS AND TUNING OF THE MHC II PRESENTED PEPTIDOME
$462,749Laura Santambrogio · Albert Einstein College Of Medicine, Inc · R01 · FY2018 · AI
Chemical Address Tags: A Cheminformatics & Image Data Management and Analysis Pla
$462,719Gus R Rosania · University Of Michigan At Ann Arbor · R01 · FY2012 · GM
International Tuberculosis Research in China
$462,630Clifton Barry · National Institute Of Allergy And Infectious Diseases · ZIA · FY2014 · AI
EXPRESSION OF TUBERCULOSIS IN THE LUNG
$462,590Univ Of Med/Dent Of Nj-Nj Medical School · R01 · FY2004 · HL
A dual-layer flat panel x-ray detector based on an engineered amorphous chalcogenide alloy for quantifying coronary artery calcium
$462,588Shiva Abbaszadeh · University Of California Santa Cruz · R01 · FY2025 · EB
Neutrophil-intrinsic role of SLC11A1/NRAMP1 in control of bacterial infection
$462,573Renee M. Tsolis · University Of California At Davis · R01 · FY2019 · AI
Morehouse School of Medicine (M-MIDARP)
$462,556Ronald Lloyd Braithwaite · Morehouse School Of Medicine · R24 · FY2008 · DA
Defining drivers of TB transmission in the era of universal ART, and implications for finding the walking well
$462,515Alison Grant · London Sch/Hygiene & Tropical Medicine · R01 · FY2022 · AI
Schistosoma Mansoni Infection During Pregnancy: Dissecting the Implications to Fetal Immunity
$462,499Keke Celeste Fairfax · University Of Utah · R01 · FY2020 · AI
Schistosoma Mansoni Infection During Pregnancy: Dissecting the Implications to Fetal Immunity
$462,499Keke Celeste Fairfax · University Of Utah · R01 · FY2021 · AI
Schistosoma Mansoni Infection During Pregnancy: Dissecting the Implications to Fetal Immunity
$462,499Keke Celeste Fairfax · University Of Utah · R01 · FY2022 · AI
Large-Scale Conformational Changes in Regulation of Transcription Initiation
$462,400M. Thomas Record · University Of Wisconsin-Madison · R01 · FY2008 · GM
A novel hyper-immunogenic low virulent BCG vaccine against tuberculosis
$462,379Subramanian Dhandayuthapani · Texas Tech University Health Sciences Center At El Paso · R01 · FY2023 · AI
HIV-1 regulation by MTb: pathogen and host factor
$462,373Anne Goldfeld · Immune Disease Institute, Inc. · R01 · FY2006 · AI
Do HIV-infected Alveolar Macrophages represent a cART-resistant Reservoir?
$462,345David G Russell · Cornell University · R56 · FY2016 · AI
REU Site: Program in Molecular Biosciences
$462,342Aaron J Sholders · Colorado State University · · FY2025 · BIO
Process and pathway based discovery of novel anti-TB drugs
$462,116David Alland · Rbhs-New Jersey Medical School · U19 · FY2016 · AI
Impact of TB on Outcome of HIV in Pregnant Women
$462,016Richard E Chaisson · Johns Hopkins University · R01 · FY2014 · HD